FGF21 and obesity due to melanocortin 4 receptor deficiency: FGF21 has been shown to play a key role in the control of many aspects of energy homeostasis in both preclinical and clinical studies, and it represents an interesting candidate for the treatment of obesity and type 2 diabetes (Dolegowska et al., 2019).